Cargando…
Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
Thyroid eye disease (TED) causes orbital soft-tissue expansion. Recent studies have suggested that brow and temple changes may also occur. Teprotumumab, a monoclonal antibody to the insulin-like growth factor 1 receptor reduces soft-tissue swelling in TED. In this study, we quantified the changes to...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443810/ https://www.ncbi.nlm.nih.gov/pubmed/34549003 http://dx.doi.org/10.1097/GOX.0000000000003809 |